The Market Tells Usright now the market is telling us there is a proliferation of approved tests recently in the U.S. and because this management has been slow off the mark they are now paying the piper. As I have said before if this company gets it's FDA approval their market is NOT the U.S. but Canada, U.K., Europe and the middle east for the most part. That is their ace in the hole. So we sit and wait to see what happens with the FDA. Just leaving the dock for fishing talk more tomorrow.